PillProgesterone
Progesterone
4 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Actavis Pharma, Inc. | unknown | 1 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 1 | SUPPLYING |
| Eugia US LLC | unknown | 1 | SUPPLYING |
| Xiromed, LLC. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Dec 27, 2024RECALLRecall (Class II): Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US L…
Presence of Particulate Matter: A market complaint was received of a glass piece in the vial. — Recalling firm: Eugia US LLC — Distributed Nationwide in the USA.
- Jul 26, 2024RECALLRecall (Class II): Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US…
Presence of Particulate Matter: Complaint received of a glass particle in the vial. — Recalling firm: Eugia US LLC — Nationwide in the USA